Replay available

Glaukos Corporation (GKOS) Q4 2025 Earnings Call

Glaukos Corporation (NYSE: GKOS) Q4 2025 earnings conference call, held 2026-02-17. Replay captured from the company's public earnings webcast.

Tue, February 17, 2026 at 4:00 PMendedReplay
Glaukos Corporation (GKOS) Q4 2025 Earnings Call

Investor webinar replay

Latest press releases

Companies on this event

Featured Presenters

Joanne Grinch

Analyst at Citibank

Richard Newitter

Analyst at Truist

Adam Mader

Analyst at Piper Sandler

Alan Gong

Analyst at JPMorgan

Larry Beagleson

Analyst at Wells Fargo

Ryan Zimmerman

Analyst at BTIG

Steve Lichtman

Analyst at William Blair

Tom Steven

Analyst at Staple

Tom Burns

Chairman and Chief Executive Officer

David Saxon

Analyst at Needham

Mason Carrico

Analyst at Stephens

Joe Gilliam

President and Chief Operating Officer

Chris Lewis

Vice President of Investor Relations and Corporate Affairs

Alex Thurmond

Chief Financial Officer

Replay transcript excerpt

Hello, and thank you for standing by. My name is Tiffany, and I will be your conference operator today. At this time, I would like to welcome everyone to Gloucester's fourth quarter and full year 2025 financial results conference call. All lines have been placed on mute to prevent any background noise. After the speaker's remarks, there will be a question and answer session. If you would like to ask a question during that time, Simply press star, then the number one on your telephone keypad. I would now like to turn the call over to Chris Lewis, Vice President of Investor Relations and Corporate Affairs. Chris, please go ahead. Thank you and good afternoon. Joining me today are Galacos Chairman and CEO Tom Burns, President and COO Joe Gilliam, and CFO Alex Thurmond. Similar to prior quarters, the company has posted a document on its investor relations website under the financials and filings quarterly results section titled quarterly summary. This document is designed to be read by investors before the regularly scheduled quarterly conference call. To ensure ample time and opportunity to address everyone's questions, we request that you limit yourself to one question and one follow up. If you still have additional questions, you may get back into the queue. Please note that all statements other than statements of historical facts made on this call that address activities, events, or developments we expect, believe, or anticipate will or may occur in the future are forward-looking statements. These include statements about our plans, objectives, strategies, and prospects regarding, among other things, our sales, products, pipeline technologies and clinical trials, U.S. and international commercialization, market development efforts, product approvals, the efficacy of ...

More from Glaukos Corporation